SYRE icon

Spyre Therapeutics
SYRE

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$60
14% downside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Julian Harrison
100% 1-yr SYRE win rate
16 Mar ‘26 1 month ago
Wells Fargo
Wells Fargo
Yanan Zhu
100% 1-yr SYRE win rate
20 Feb ‘26 1 month ago